文献速递心血管MR

峰值肌钙蛋白与心脏磁共振指导疑似ACS且冠脉非阻塞患者的诊疗

Peak Troponin and CMR to Guide Management in Suspected ACS and Nonobstructive Coronary Arteries.
PubMed 文献 · JACC Cardiovasc Imaging · 2022-05-11

本研究纳入719例疑似急性冠脉综合征且冠脉非阻塞患者,评估心脏磁共振(CMR)诊断产出率,并探索峰值肌钙蛋白T联合CMR的最佳诊断切点。结果显示峰值肌钙蛋白T≥211 ng/L且14天内行CMR的诊断产出率达94%,而峰值肌钙蛋白T<211 ng/L且14天后行CMR则降至53%。

要点

  • 峰值肌钙蛋白T≥211 ng/L且14天内行CMR,诊断产出率高达94%。
  • 峰值肌钙蛋白T<211 ng/L且14天后行CMR,诊断产出率仅53%。
  • 峰值肌钙蛋白每升高1个十分位,CMR识别诊断的比值比增加20%。

核心结论

  • 14天内行CMR且峰值肌钙蛋白T≥211 ng/L时诊断产出率极高(94%)。
  • 即使14天后行CMR,诊断产出率仍较高(72%),但峰值肌钙蛋白T<211 ng/L时降至53%。
  • 峰值肌钙蛋白每升高1个十分位,CMR识别诊断的比值比增加20%(OR: 1.20; P = 0.008, 95% CI: 1.05-1.36)。

研究设计与样本

  • 连续纳入疑似ACS且冠脉非阻塞且无明确病因的患者,行CMR检查。
  • 共719例患者符合纳入标准。
  • 使用Youden指数确定峰值肌钙蛋白T最佳诊断切点。
  • 采用logistic或Cox回归模型评估CMR诊断的预测因素。

诊断标准与关键数值

  • 峰值肌钙蛋白T最佳诊断敏感度和特异度的切点为211 ng/L。
  • CMR总体诊断产出率为74%。
  • 14天内行CMR且峰值肌钙蛋白T≥211 ng/L(n=198)时诊断产出率为94%,而14天后行CMR(n=245)为72%。
  • 14天内行CMR且峰值肌钙蛋白T<211 ng/L(n=86)时诊断产出率为76%,而14天后行CMR(n=190)为53%。

临床应用与阅片要点

  • 对疑似ACS且冠脉非阻塞患者,应结合峰值肌钙蛋白T水平及距就诊时间优化CMR检查时机。
  • 峰值肌钙蛋白T≥211 ng/L时,推荐14天内行CMR以最大化诊断产出率。
  • 峰值肌钙蛋白T<211 ng/L时,也应尽早(14天内)行CMR,避免诊断产出率下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Patients presenting with acute coronary syndrome (ACS) and nonobstructive coronary arteries are a diagnostic dilemma. Cardiac magnetic resonance (CMR) has an overall diagnostic yield of ∼75%; however, in ∼25% of patients, CMR does not identify any myocardial injury. Identifying the underlying diagnosis has important clinical implications for patients' management and outcome.

OBJECTIVES: The authors sought to assess whether the combination of CMR and peak troponin levels in patients with ACS and nonobstructive coronary arteries would lead to increased diagnostic yield.

METHODS: Consecutive patients with ACS and nonobstructive coronary arteries without an obvious cause underwent CMR. The primary endpoint of the study was the diagnostic yield of CMR. The Youden index was used to find the optimal diagnostic cut point for peak troponin T to combine with CMR to improve diagnostic yield. Logistic or Cox regression models were used to estimate predictors of a diagnosis by CMR.

RESULTS: A total of 719 patients met the inclusion criteria. The peak troponin T threshold for optimal diagnostic sensitivity and specificity was 211 ng/L. Overall, CMR has a diagnostic yield of 74%. CMR performed <14 days from presentation and with a peak troponin of ≥211 ng/L (n = 198) leads to an improved diagnostic yield (94% vs 72%) compared with CMR performed ≥14 days (n = 245). When CMR was performed <14 days and with a peak troponin of <211 ng/L, the diagnostic yield was 76% (n = 86) compared with 53% (n = 190) when performed ≥14 days. An increase in 1 peak troponin decile increases the odds of the CMR identifying a diagnosis by 20% (OR: 1.20; P = 0.008, 95% CI: 1.05-1.36).

CONCLUSIONS: The combination of CMR performed <14 days from presentation and peak troponin T ≥211 ng/L leads to a very high diagnostic yield (94%) on CMR. The diagnostic yield remains high (72%) even when CMR is performed ≥14 days from presentation, but reduces to 53% when peak troponin T was <211 ng/L.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Williams, Liang, De Garate, et al. Peak Troponin and CMR to Guide Management in Suspected ACS and Nonobstructive Coronary Arteries. JACC Cardiovasc Imaging. 2022. PMID: 36075617. doi:10.1016/j.jcmg.2022.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。